Super-enhancers in tumors: unraveling recent advances in their role in Oncogenesis and the emergence of targeted therapies

被引：0

作者：

Ji, Yumeng ^{[1
]}

Li, Baixue ^{[1
]}

Lin, Rongjin ^{[1
]}

Yuan, Jing ^{[1
]}

Han, Yang ^{[1
]}

Du, Yuping ^{[1
,2
]}

Zhao, Yang ^{[1
,2
]}

机构：

[1] Guangzhou Med Univ, Affiliated Hosp 3, Guangdong Prov Clin Res Ctr Obstet & Gynecol, Dept Obstet & Gynecol,Dept Gynecol Oncol Res Off,G, Guangzhou, Peoples R China

[2] 63 Duobao Rd, Guangzhou, Guangdong, Peoples R China

来源：

JOURNAL OF TRANSLATIONAL MEDICINE | 2025年 / 23卷 / 01期

基金：

中国国家自然科学基金;

关键词：

Super enhancer; Transcription regulatory; Cancer; Targeted therapy; DRIVEN TRANSCRIPTIONAL DEPENDENCIES; HISTONE DEACETYLASE INHIBITOR; PROSTATE-CANCER; CELL IDENTITY; SELECTIVE-INHIBITION; PHASE-SEPARATION; BET INHIBITORS; BRD4; EXPRESSION; MEDIATOR;

D O I：

10.1186/s12967-025-06098-x

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Super enhancers are a unique class of enhancers that possess a distinct structure and mechanism, which enable them to exhibit stronger gene transcription regulatory function than classical enhancers, thereby regulating cellular activities. In tumor samples, super enhancers have been identified as crucial players in the development and progression of tumor cells, opening up new avenues for cancer research and treatment. This review provides a concise overview of various models regarding super enhancer assembly and activation, examining the mechanisms through which tumor cells acquire or activate these enhancers and regulate carcinogenic transcription programs. Furthermore, we discuss the current landscape and challenges in developing cancer therapeutic drugs that target super enhancers.

引用

页数：17

共 159 条

[61] Super-Enhancers in the Control of Cell Identity and Disease
Hnisz, Denes
Abraham, Brian J.
Lee, Tong Ihn
Lau, Ashley
Saint-Andre, Violaine
Sigova, Alla A.
Hoke, Heather A.
Young, Richard A.
[J]. CELL, 2013, 155 (04) : 934 - 947
[62] Targeted protein degradation via intramolecular bivalent glues
Hsia, Oliver
Hinterndorfer, Matthias
Cowan, Angus D.
Iso, Kentaro
Ishida, Tasuku
Sundaramoorthy, Ramasubramanian
Nakasone, Mark A.
Imrichova, Hana
Schaetz, Caroline
Rukavina, Andrea
Husnjak, Koraljka
Wegner, Martin
Correa-Saez, Alejandro
Craigon, Conner
Casement, Ryan
Maniaci, Chiara
Testa, Andrea
Kaulich, Manuel
Dikic, Ivan
Winter, Georg E.
Ciulli, Alessio
[J]. NATURE, 2024, 627 (8002) : 204 - +
[63] Defining super-enhancer landscape in triple-negative breast cancer by multiomic profiling
Huang, Hao
Hu, Jianyang
Maryam, Alishba
Huang, Qinghua
Zhang, Yuchen
Ramakrishnan, Saravanan
Li, Jingyu
Ma, Haiying
Ma, Victor W. S.
Cheuk, Wah
So, Grace Y. K.
Wang, Wei
Cho, William C. S.
Zhang, Liang
Chan, Kui Ming
Wang, Xin
Chin, Y. Rebecca
[J]. NATURE COMMUNICATIONS, 2021, 12 (01)
[64] Design, synthesis and mechanism studies of novel dual PARP1/BRD4 inhibitors against pancreatic cancer
Huang, Shi-Hui
Cao, Ran
Lin, Qian-Wen
Wu, Shi-Qi
Gao, Ling-Li
Sun, Qin
Zhu, Qi-Hua
Zou, Yi
Xu, Yun-Gen
Wang, Shu-Ping
[J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 230
[65] The Leukemogenic TCF3-HLF Complex Rewires Enhancers Driving Cellular Identity and Self-Renewal Conferring EP300 Vulnerability
Huang, Yun
Mouttet, Brice
Warnatz, Hans-Joerg
Risch, Thomas
Rietmann, Fabian
Frommelt, Fabian
Ngo, Quy A.
Dobay, Maria Pamela
Marovca, Blerim
Jenni, Silvia
Tsai, Yi-Chien
Matzk, Soeren
Amstislavskiy, Vyacheslav
Schrappe, Martin
Stanulla, Martin
Gstaiger, Matthias
Bornhauser, Beat
Yaspo, Marie-Laure
Bourquin, Jean-Pierre
[J]. CANCER CELL, 2019, 36 (06) : 630 - +
[66] The Megacomplex protects ER-alpha from degradation by Fulvestrant in epithelial ovarian cancer
Jaiswal, Sushil Kumar
Fedkenheuer, Kevin
Khamar, Ronak
Tan, Hua
Gotea, Valer
Raj, Sonam
Fedkenheuer, Michael
Elkahloun, Abdel
Zhao, Ming
Jenkins, Lisa M.
Annunziata, Christina M.
Elnitski, Laura
[J]. CANCER LETTERS, 2025, 608
[67] Opposing effects of cancer-type-specific SPOP mutants on BET protein degradation and sensitivity to BET inhibitors
Janouskova, Hana
El Tekle, Geniver
Bellini, Elisa
Udeshi, Namrata D.
Rinaldi, Anna
Ulbricht, Anna
Bernasocchi, Tiziano
Civenni, Gianluca
Losa, Marco
Svinkina, Tanya
Bielski, Craig M.
Kryukov, Gregory V.
Cascione, Luciano
Napoli, Sara
Enchev, Radoslav I.
Mutch, David G.
Carney, Michael E.
Berchuck, Andrew
Winterhoff, Boris J. N.
Broaddus, Russell R.
Schraml, Peter
Moch, Holger
Bertoni, Francesco
Catapano, Carlo V.
Peter, Matthias
Carr, Steven A.
Garraway, Levi A.
Wild, Peter J.
Theurillat, Jean-Philippe P.
[J]. NATURE MEDICINE, 2017, 23 (09) : 1046 - +
[68] Microbial metabolite enhances immunotherapy efficacy by modulating T cell stemness in pan-cancer
Jia, Dingjiacheng
Wang, Qiwen
Qi, Yadong
Jiang, Yao
He, Jiamin
Lin, Yifeng
Sun, Yong
Xu, Jilei
Chen, Wenwen
Fan, Lina
Yan, Ruochen
Zhang, Wang
Ren, Guohong
Xu, Chaochao
Ge, Qiwei
Wang, Lan
Liu, Wei
Xu, Fei
Wu, Pin
Wang, Yuhao
Chen, Shujie
Wang, Liangjing
[J]. CELL, 2024, 187 (07) : 1651 - 1665.e21
[69] Super Enhancer-Mediated Upregulation of HJURP Promotes Growth and Survival of t(4;14)-Positive
Jia, Yunlu
Zhou, Jianbiao
Tan, Tze King
Chung, Tae-Hoon
Chen, Yongxia
Chooi, Jing-Yuan
Sanda, Takaomi
Fullwood, Melissa J.
Xiong, Sinan
Toh, Sabrina H. M.
Balan, Kalpnaa
Wong, Regina W. J.
Lim, Julia S. L.
Zhang, Enfan
Cai, Zhen
Shen, Peng
Chng, Wee Joo
[J]. CANCER RESEARCH, 2022, 82 (03) : 406 - 418
[70] Mediator and cohesin connect gene expression and chromatin architecture
Kagey, Michael H.
Newman, Jamie J.
Bilodeau, Steve
Zhan, Ye
Orlando, David A.
van Berkum, Nynke L.
Ebmeier, Christopher C.
Goossens, Jesse
Rahl, Peter B.
Levine, Stuart S.
Taatjes, Dylan J.
Dekker, Job
Young, Richard A.
[J]. NATURE, 2010, 467 (7314) : 430 - 435

← 2 3 4 5 6 7 8 9 10 11 →